160 related articles for article (PubMed ID: 22012030)
21. Autologous Plasma Rich in Growth Factors Eyedrops in Refractory Cases of Ocular Surface Disorders.
Merayo-Lloves J; Sanchez RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
Ophthalmic Res; 2015; 55(2):53-61. PubMed ID: 26569104
[TBL] [Abstract][Full Text] [Related]
22. Ligamentization of tendon grafts treated with an endogenous preparation rich in growth factors: gross morphology and histology.
Sánchez M; Anitua E; Azofra J; Prado R; Muruzabal F; Andia I
Arthroscopy; 2010 Apr; 26(4):470-80. PubMed ID: 20362825
[TBL] [Abstract][Full Text] [Related]
23. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
[TBL] [Abstract][Full Text] [Related]
24. [Dry eye--etiopathogenic and histopathologic correlations].
Stan C; Mera M; Samoilă O; Bedeoan S
Oftalmologia; 2007; 51(3):86-90. PubMed ID: 18064961
[TBL] [Abstract][Full Text] [Related]
25. Phase III safety evaluation of cyclosporine 0.1% ophthalmic emulsion administered twice daily to dry eye disease patients for up to 3 years.
Barber LD; Pflugfelder SC; Tauber J; Foulks GN
Ophthalmology; 2005 Oct; 112(10):1790-4. PubMed ID: 16102833
[TBL] [Abstract][Full Text] [Related]
26. Safety and efficacy of cyclosporine 0.05% drops versus unpreserved artificial tears in dry-eye patients having laser in situ keratomileusis.
Salib GM; McDonald MB; Smolek M
J Cataract Refract Surg; 2006 May; 32(5):772-8. PubMed ID: 16765793
[TBL] [Abstract][Full Text] [Related]
27. Safety and Efficacy of Autologous Plasma Rich in Growth Factors Eye Drops for the Treatment of Evaporative Dry Eye.
Merayo-Lloves J; Sanchez-Avila RM; Riestra AC; Anitua E; Begoña L; Orive G; Fernandez-Vega L
Ophthalmic Res; 2016 Jul; 56(2):68-73. PubMed ID: 27229893
[TBL] [Abstract][Full Text] [Related]
28. Pro- and anti-inflammatory forms of interleukin-1 in the tear fluid and conjunctiva of patients with dry-eye disease.
Solomon A; Dursun D; Liu Z; Xie Y; Macri A; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2283-92. PubMed ID: 11527941
[TBL] [Abstract][Full Text] [Related]
29. Autologous serum eye drops improve tear production, both lachrymal flow and stability tests and conjunctival impression cytology with transfer in dry eye disease.
Valencia Castillo SL; Martín ES; García Frade LJ; García-Miguel FJ
Blood Transfus; 2021 Jan; 19(1):45-53. PubMed ID: 32530402
[TBL] [Abstract][Full Text] [Related]
30. Impression cytology of the conjunctival epithelial cells in patients with cystic fibrosis.
Mrugacz M; Kasacka I; Bakunowicz-Lazarczyk A; Kaczmarski M; Kulak W
Eye (Lond); 2008 Sep; 22(9):1137-40. PubMed ID: 17525773
[TBL] [Abstract][Full Text] [Related]
31. SmartPlug versus silicone punctal plug therapy for dry eye: a prospective randomized trial.
Burgess PI; Koay P; Clark P
Cornea; 2008 May; 27(4):391-4. PubMed ID: 18434839
[TBL] [Abstract][Full Text] [Related]
32. Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma.
De Paiva CS; Villarreal AL; Corrales RM; Rahman HT; Chang VY; Farley WJ; Stern ME; Niederkorn JY; Li DQ; Pflugfelder SC
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2553-60. PubMed ID: 17525184
[TBL] [Abstract][Full Text] [Related]
33. Ocular surface and tear functions after topical cyclosporine treatment in dry eye patients with chronic graft-versus-host disease.
Wang Y; Ogawa Y; Dogru M; Kawai M; Tatematsu Y; Uchino M; Okada N; Igarashi A; Kujira A; Fujishima H; Okamoto S; Shimazaki J; Tsubota K
Bone Marrow Transplant; 2008 Feb; 41(3):293-302. PubMed ID: 17982500
[TBL] [Abstract][Full Text] [Related]
34. [Therapy of dry eye disorders].
Heiligenhaus A; Koch JM; Kemper D; Kruse FE; Waubke TN
Klin Monbl Augenheilkd; 1994 Mar; 204(3):162-8. PubMed ID: 8196302
[TBL] [Abstract][Full Text] [Related]
35. [The application of the autologous serum eye drops results in significant improvement of the conjunctival status in patients with the dry eye syndrome].
Jirsová K; Hrdlicková E; Alfakih A; Juklová K; Filipec M; Faltus V; Veselá V
Cesk Slov Oftalmol; 2008 Mar; 64(2):52-6. PubMed ID: 18419102
[TBL] [Abstract][Full Text] [Related]
36. Conjunctival cytokine expression in symptomatic moderate dry eye subjects.
Narayanan S; Miller WL; McDermott AM
Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2445-50. PubMed ID: 16723455
[TBL] [Abstract][Full Text] [Related]
37. The association of bulbar conjunctival folds with other clinical findings in normal and moderate dry eye subjects.
Miller WL; Narayanan S; Jackson J; Bergmanson J
Optometry; 2003 Sep; 74(9):576-82. PubMed ID: 14515980
[TBL] [Abstract][Full Text] [Related]
38. [Impression cytology in patients with dry eye syndrome and various rheumatic diseases].
Oziebło-Kupczyk M; Sredzińska-Kita D; Kita K; Mrugacz M
Klin Oczna; 2006; 108(10-12):420-3. PubMed ID: 17455718
[TBL] [Abstract][Full Text] [Related]
39. [A new therapy concept for the treatment of dry eye--the usefulness of phospholipid liposomes].
Lee S; Dausch S; Maierhofer G; Dausch D
Klin Monbl Augenheilkd; 2004 Oct; 221(10):825-36. PubMed ID: 15499517
[TBL] [Abstract][Full Text] [Related]
40. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome.
Yoon KC; Im SK; Kim HG; You IC
Cornea; 2011 Sep; 30(9):972-6. PubMed ID: 21705877
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
